Genetic Testing Parkinsons Disease


To uncover pharmaceutical companies conducting genetic testing for Parkinson's disease and other neurological or traditionally non genetic disorders (including names of companies, drugs, trials, and specific cases of using genetics), in order to form a thoughtful business pitch.

Early Findings


We found some proprietary research from one of our data partners which may be helpful:
  • Growth Opportunities in the Neurodegenerative Disorder Therapeutics Market, Forecast to 2024, Parts 6 and 8 (Frost and Sullivan 2019, Part 6- $1,953.08, Part 8- $3242.15)
If you'd like us to purchase this report on your behalf, just let us know!

Other Findings

  • The Michael J. Fox Foundation (MJFF) conducted a survey and found that nearly 40% of those who responded do not know how to go about being tested for genetic mutations for Parkinson's.
  • The MJFF has an online clinical study called Fox Insight that offers participants with Parkinson's living in the U.S. genetic testing, reporting on mutations in two genes linked to a risk for Parkinson’s: GBA and LRRK2. Collaborating with 23andMe, a consumer genetics company, participants who are eligible can receive access to Health + Ancestry Services from 23andMe at no extra cost.
  • At Northshore University Healthshore, they have genetic testing for hereditary neurological disorders and others available. A history of the family, as well as ages at diagnosis and neurological feature are all used to determine the chances of inherited neurological conditions and, if one is suspected, the gene(s) that need analyzed. They offer gene counseling if there is a family history of alzheimer's, Huntington’s disease, epilepsy, Parkinson's disease, and strokes.
  • Other companies such as Invitae, Centogene, Ambry Genetics, and more offer genetic testing for neurological disorders.
  • The Parkinson's Foundation states that the identification of a genetic mutation can help determine eligibility to enroll in clinical trials, several of which are already testing treatments for those carrying certain PD gene mutations in LRRK2 and GBA genes.
  • Genetic tests are either not available or not affordable for those with Parkinson's, and tests are not covered by health insurance or offered through gene counseling. Studies such as PD GENEration are currently offering free genetic testing and genetic counseling.
  • Genetic testing for Parkinson's is currently only available through a doctor for the genes: GBA, PINK1, SNCA, PARK7, LRRK2, and parkin. Tests for home only look for one of a variety of changes in LRRK2 (G2019S) and GBA (N370S) and do not have the capabilities to map the entire gene for other mutations, (one a major goal of PD GENEration.)

Proposed next steps:

You need to be the project owner to select a next step.